GlycoMimetics Inc. (GLYC)
0.25
-0.01 (-3.36%)
At close: Mar 04, 2025, 2:14 PM
GlycoMimetics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 10.72M | 41.79M | 47.87M | 90.25M | 137.03M | 158.2M | 209.92M | 123.92M | 40.04M | 46.8M | 55.2M | 2.31M | 17.37M | 28.17M |
| Short-Term Investments | 10.71B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.65K | 9.27K | 16.29K | 1K | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | 757.91K | 102.32K | 2.15M | 1.61M | 1.61M | 1.61M | 256.68K | 811.85K | 696.53K | 696.53K | n/a | -450.76K | 308.52K |
| Receivables | 136.58K | 175.82K | 144.02K | 1.35K | 2.15K | 185.95K | 413.12K | 101.95K | 268.66K | 38.68K | 22.33K | n/a | n/a | n/a |
| Inventory | n/a | n/a | -144.4K | -533.81M | -1.24B | -4.32B | -405 | n/a | 198.84K | 393.42K | -77 | n/a | n/a | n/a |
| Other Current Assets | 371.28M | 1.82M | 2.7M | 532.46K | 1.24M | 4.14M | 1.94M | 3.19M | 209.84K | 403.13K | 852.51K | 2.57M | 596.18K | 194.21K |
| Total Current Assets | 11.09B | 43.79M | 50.71M | 90.25M | 138.27M | 162.53M | 212.27M | 127.22M | 40.52M | 47.24M | 56.12M | 4.88M | 17.97M | 28.37M |
| Property-Plant & Equipment | n/a | 767.83K | 993.56K | 1.95M | 2.95M | 3.83M | 957.23K | 1.11M | 1.06M | 521.38K | 452.27K | 399.8K | 450.76K | 234.5K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | n/a | 1.53M | 1.1M | 4.09M | 4.56M | 5.44M | 2.57M | 1.36M | 1.87M | 1.22M | 1.15M | 399.8K | 450.76K | 543.02K |
| Total Assets | 11.09B | 45.32M | 51.81M | 94.35M | 142.83M | 167.97M | 214.84M | 128.58M | 42.39M | 48.46M | 57.26M | 5.28M | 18.42M | 28.91M |
| Account Payables | 329.3K | 868.12K | 970.19K | 2.11M | 2.09M | 1.44M | 2.66M | 2.65M | 1.57M | 564.24K | 874.03K | 1.14M | 764.2K | 535.6K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 68.55K | n/a | n/a | n/a | 3.99M | 15M |
| Short-Term Debt | 66.91M | 741.56K | 918.55K | 1M | 898.55K | 804.13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 5.71B | 5.23M | 6.99M | 8.72M | 9.44M | 8.71M | 6.1M | 5.53M | 4.77M | 7.18M | 5.59M | 1.13M | 934.71K | 826.6K |
| Total Current Liabilities | 5.78B | 6.84M | 8.88M | 11.82M | 12.43M | 10.95M | 8.76M | 8.17M | 6.33M | 7.75M | 6.46M | 2.28M | 5.69M | 16.41M |
| Long-Term Debt | n/a | 66.84K | n/a | 918.61K | 1.92M | 2.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 264.33K | n/a | 611.62K | 707K | 753.58K | 243.65K | n/a | 96.76K | 199.83K | n/a |
| Total Long-Term Liabilities | n/a | 66.84K | 1.89M | 918.61K | 2.18M | 2.82M | 611.62K | 707K | 753.58K | 243.65K | n/a | 96.76K | 199.83K | 4.04M |
| Total Liabilities | 5.78B | 6.9M | 8.88M | 12.74M | 14.61M | 13.77M | 9.38M | 8.88M | 7.09M | 7.99M | 6.46M | 2.38M | 5.89M | 20.45M |
| Total Debt | 66.84M | 808.4K | 918.55K | 1.92M | 2.82M | 3.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock | 64.48K | 64.39K | 54.38K | 52.31K | 49.02K | 43.47K | 43.16K | 34.36K | 23.25K | 19.05K | 18.94K | 1.43K | 10.23K | 930.00 |
| Retained Earnings | -494.36B | -456.49M | -419.59M | -372.9M | -309.47M | -258.44M | -200.55M | -152.28M | -118.98M | -87.17M | -74.4M | -63.28M | -52.67M | -56.33M |
| Comprehensive Income | n/a | n/a | n/a | n/a | n/a | 0.00 | -1.58M | -1.31M | -1.06M | -902.1K | -905.48K | -755.91K | -796.18K | -696.26K |
| Shareholders Equity | 5.31B | 38.41M | 42.93M | 81.6M | 128.22M | 154.2M | 205.46M | 119.7M | 35.3M | 40.47M | 50.8M | 2.91M | 12.53M | 8.46M |
| Total Investments | 10.71B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.65K | 9.27K | 16.29K | 1K | n/a | n/a |